Cart (0 Items)
Your cart is currently empty.
View ProductsEnoticumab Biosimilar – Anti-DLL4 mAb – Research Grade
| Size | |
|---|---|
| Brand | |
| Product type | |
| Clonality | |
| Expression system | |
| Applications |
| Product name | Enoticumab Biosimilar - Anti-DLL4 mAb - Research Grade |
|---|---|
| Source | CAS 1192578-27-0 |
| Species | Homo sapiens |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Applications | ELISA,WB |
| Aliases /Synonyms | Enoticumab,REGN-421,SAR153192,DLL4 ,anti-DLL4 |
| Reference | PX-TA1291 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG1-kappa |
| Clonality | Monoclonal Antibody |
Description of Enoticumab Biosimilar - Anti-DLL4 mAb - Research Grade
General information on Anti-DLL4 [Homo sapiens] (Enoticumab) Monoclonal Antibody
Enoticumab has been investigated for the treatment of Solid Tumors.
Related products
Antigen
Human DLL4 recombinant protein
PX-P5121 110€
Isotype Control
Human IgG1 LALA Isotype Control antibody (HyHEL-10)
PTX17885 180€
SIL
Reviews
Il n’y a pas encore d’avis.